Lung Cancer, Small Cell
Oncology·MeSH: Neoplasms
Prevalence
30.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| gen-011 | GENOCEA BIOSCIENCES, INC. (GNCA) |
Frequently asked questions
How many drugs are in development for Lung Cancer, Small Cell?
BioSniper tracks 1 drug in development for Lung Cancer, Small Cell across 1 company.
How many clinical trials target Lung Cancer, Small Cell?
There are 1 clinical trial targeting Lung Cancer, Small Cell tracked by BioSniper.
What is the prevalence of Lung Cancer, Small Cell?
The estimated prevalence of Lung Cancer, Small Cell is approximately 30.0 per 100,000 population.
Deep-dive into Lung Cancer, Small Cell
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis